Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03126123
Other study ID # 69HCL16_0550
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 7, 2017
Est. completion date July 31, 2018

Study information

Verified date January 2019
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anal condylomatosis is an anal canal mucosa pathology caused by HPV infection (Human Papilloma Virus). This condition is common, especially in immunodepressed patients.

These lesions are not accessible to topical medical treatment because of their location. They should be treated surgically because they may degenerate into squamous cell carcinoma.

In the operating room, lesions are identified by a complete proctologic examination, more or less supplemented by an acetic acid test. Acetic acid allows to detect mucous degeneration (dysplasia) in the form of intense bleaching. The interpretation of this test may nevertheless be difficult in case of local inflammation or scarring. These false positives may lead to unnecessary surgical gestures. The surgical procedure consists of a mucosectomy or destruction of the condylomatosis by electrocoagulation.

The acetic acid test is used at the discretion of the surgeon. However, there is little data on its performance or consensus on its use.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date July 31, 2018
Est. primary completion date July 31, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age = 18 years

- programmed surgery for anal condylomatosis in the visceral surgery department of the Hôpital de la Croix Rousse in Lyon

- patient in receipt of the social security scheme

- patient who did not oppose his participation in the study.

Exclusion Criteria:

- Pregnant women

- Patients protected by law

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
acetic acid test
Patients will receive acetic acid on the mucosa of the anal canal before the surgical procedure

Locations

Country Name City State
France Hopital de la Croix Rousse Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Positive predictive value of the acetic acid test in comparison with the anatomopathological analysis of the biopsies performed on the lesions revealed by acetic acid Application of acetic acid just before surgery to identify suspect areas of dysplasia.
Biopsies of suspicious areas bleached with acetic acid. The true positives (TP) will correspond to lesions bleached by acetic acid and showing dysplasia at biopsy. False positives (FP) will correspond to lesions bleached by acetic acid but not showing dysplasia at biopsy. The positive predictive value (PPV) will be the proportion of TP over the total number of bleached lesions. (PPV = TP / (TP + FP)). The PPV will be given with its 95% confidence interval (95%CI).
the day of surgery
Secondary Evaluation of the toxicity of the acetic acid test Collection of adverse events associated with acetic acid use in peroperative time the day of surgery
Secondary Identify a patient subgroup in which the acetic acid test would be particularly discriminatory Pre-surgery data collection on patient file at pre operative visit up to 5 months before surgery
Secondary post-surgery pain self-assessed using a visual analog scale at 5; 12 hours post surgery;at Day 1; Day 2 ; Day 3; Day 7 ; Day 14; Day 21 post surgery; 1 month post-surgery up to 1 month post surgery
Secondary change in post-surgery incontinence evaluation with the Wexner score (anal incontinence score used internationally) before surgery (at pre operative visit) and 1 month post-surgery up to 5 months before surgery and 1 month post surgery
Secondary Clinical recurrence of anal condylomatosis 1 month post surgery
Secondary Duration of sick leave number of days of sick leave 1 month post surgery
Secondary Number of unscheduled medical visits 1 month post surgery
See also
  Status Clinical Trial Phase
Completed NCT02402543 - Pre-Emptive Analgesia in Ano-Rectal Surgery N/A
Recruiting NCT03241680 - Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III) N/A